Prognostication and treatment predictions for estrogen receptor positive early-stage breast cancer: incorporating the 70-gene signature into the PREDICT prognostication model.
AuteursEngelhardt EG, Binuya MAE, Pharoah PDP, Poncet C, Rutgers EJT, Piccart M, Cardoso F, van 't Veer LJ, Steyerberg EW, Linn SC, Schmidt MK
Optimal treatment duration in metastatic renal cell carcinoma patients responding to immune checkpoint inhibitors: should we treat beyond two years?
AuteursDecruyenaere A, Christine G, Sylvie R, Annouschka L, Seront E, Everaert E, Debruyne PR, Van Den Bulck H, Bastin J, Annelies V, Vulsteke C, Schatteman P, Luyten D, Aspeslagh S, Martinez-Chanza N, De Bock M, Meyskens T, Verheezen J, Brouwers B, Beuselinck B
Human papillomavirus infection is a favorable prognostic factor for patients with stage I-IVA esophageal squamous cell carcinoma but not adenocarcinoma.
AuteursReynders C, Bruyere D, Roncarati P, Geuzaine R, Koopmansch B, Gofflot S, Monnien F, Craciun L, Piazzon N, Hendrick E, Poulain F, Lerho T, Miceli S, Pilard C, Ancion M, Luyckx M, Renard M, Lambert F, Gheit T, Molimard C, Bibeau F, Larsimont D, Fasquelle F, de Leval L, Delvenne P, Kervarrec T, Hubert P, Peulen O, Herfs M
Expression of Membrane Targets for Therapeutics in RET-Positive Non-Small Cell Lung Cancer.
AuteursMarinello A, Ghigna MR, Rotow JK, Adeyelu T, Metro G, Brandão M, Guisier F, Monnet I, Gaultier de Saint Basile H, Genova C, Raimbourg J, Terrisse S, Godefroy K, Toschi L, Mandarano M, Doubre H, Russo A, Valent A, Naqash AR, Aijaz A, Gazzah A, Remon J, Vanderwalde A, Elliott A, Halmos B, Barlesi F, Planchard D, Jänne PA, Besse B, Aldea M
